Showing results (591-600 of 6,760) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|July 16, 2003
Cost-minimization analysis of pegylated liposomal doxorubicin versus topotecan for the treatment of ovarian cancer in ItalyStefano Capri, Giulio CattaneoClinical Therapeutics|July 11, 2003
The use of gabapentin for the treatment of postherpetic neuralgiaDevada Singh, Deborah H KennedyClinical Therapeutics|July 11, 2003
Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000Judith A O'Brien, Amanda R Patrick, Jaime CaroClinical Therapeutics|July 1, 1992
Bioavailability of medroxyprogesterone acetate from three oral dosage formulationsD J Stalker, I R Welshman, S R PollockClinical Therapeutics|March 1, 1992
Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitisP M Bédard, J Del Carpio, M A Drouin, et al.Clinical Therapeutics|September 27, 2003
An overview of targeted treatments in cancerRony Abou-Jawde, Toni Choueiri, Carlos Alemany, et al.Clinical Therapeutics|September 27, 2003
A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthmaPiotr Kuna, James R Joubert, Louis A P M Greefhorst, et al.Clinical Therapeutics|September 27, 2003
A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteersPaul D Martin, Mike J Warwick, Aaron L Dane, et al.Clinical Therapeutics|September 27, 2003
Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy menJosé Villacampa, Fernando Alcántar, Juan Manuel Rodríguez, et al.Pageof 676